Concurrent cisplatin or cetuximab with radiotherapy for HPV-positive oropharyngeal cancer: medical resource use, costs, and quality-adjusted survival from the De-ESCALaTE HPV trial

GRAY A., JONES D.

Type

Journal article

Publisher

Elsevier

Publication Date

2019-10-30T00:00:00+00:00

Permalink Close